Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FPQZ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,500
Award facts
- Contract value 100% obligated
- $97,499.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026. The delivery order carries no set-aside designation, and performance will occur at the vendor's location in Park Ridge, Illinois.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. Stelara, an immunosuppressive biologic therapy, supports the DLA's mission to supply pharmaceutical products to military health facilities. The vendor's robust track record and woman-owned small business status have enabled it to compete effectively across multiple delivery orders covering diverse therapeutic categories, ranging from oncology treatments to specialty injections and vaccines, positioning the company as a trusted partner for government healthcare procurement.
Quick answers
Who was awarded contract SPE2DB25FPQZ9?
SPE2DB25FPQZ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FPQZ9 worth?
The government has obligated $97,500 on SPE2DB25FPQZ9.
Is contract SPE2DB25FPQZ9 an order under another contract?
Yes. SPE2DB25FPQZ9 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQZ9 competed?
The extent of competition for SPE2DB25FPQZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award